Sector: University & Research Institutions

Latest content

An almost billion-dollar award leads 2022’s top 10 US patent verdicts

Companies who scored the most from US juries during the past 12 months include VLSI Technology, Complete Genomics Inc, Ravgen Inc, USAA and Columbia University

19 December 2022

Patent bills prominent but prospects mixed as US Congress winds down

Controversial Pride in Patent Ownership bill unlikely, other bills passed or possible

16 December 2022

Diversity data reveals size of missed opportunities in inventors and patenting

Qualcomm executive and Invent Together director discuss initiatives at IP Dealmakers conference in New York

13 December 2022

Your guide to synthetic drug royalty dealmaking

Selling revenue streams is an increasingly important way of monetising pharma innovations

16 November 2022

Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line

04 November 2022

France Brevets’ public sector links hindered monetisation efforts, says CEO

As the sovereign patent fund closes down, CEO Didier Patry shares his thoughts with IAM readers on the organisation’s work over the past decade

03 November 2022

The key to success: technology transfer tips for university and research IP managers

The role of the technology transfer office is crucial for getting products to market. Implementing well thought-out strategies will allow these to flourish in your organisation.

19 October 2022

Qualcomm seeks focus on patent quality over quantity to power US in global tech race

Company chief economist Kirti Gupta speaks with IAM about how better to assess leadership in the wireless and semiconductor industries

12 October 2022

Soaring US patent litigation funding triggers intense disclosure debate

Third-party backing is at an all-time high, but questions linger over how much should be public

07 October 2022

Reform of Section 101 should be part of US government technology policy

Saturday Opinion: Without a coherent approach to capturing domestic value from R&D including greater clarity on subject matter patentability, the positive consequences of higher US government funding will be felt as much in Berlin, Bangalore and Beijing as Boston

24 September 2022

Unlock unlimited access to all IAM content